Few microbial functions have been compared to a comprehensive survey of the human fecal microbiome. We evaluated determinants of fecal microbial β-glucuronidase and β-glucosidase activities, focusing especially on associations with microbial alpha and beta diversity and taxonomy. We enrolled 51 healthy volunteers (26 female, mean age 39) who provided questionnaire data and multiple aliquots of a stool, from which proteins were extracted to quantify β-glucuronidase and β-glucosidase activities, and DNA was extracted to amplify and pyrosequence 16S rRNA gene sequences to classify and quantify microbiome diversity and taxonomy. Fecal β-glucuronidase was elevated with weight loss of at least 5 lb. (P = 0.03), whereas β-glucosidase was marginally reduced in the four vegetarians (P = 0.06). Both enzymes were correlated directly with microbiome richness and alpha diversity measures, directly with the abundance of four Firmicutes Clostridia genera, and inversely with the abundance of two other genera (Firmicutes Lactobacillales Streptococcus and Bacteroidetes Rikenellaceae Alistipes) (all P = 0.05–0.0001). Beta diversity reflected the taxonomic associations. These observations suggest that these enzymatic functions are performed by particular taxa and that diversity indices may serve as surrogates of bacterial functions. Independent validation and deeper understanding of these associations are needed, particularly to characterize functions and pathways that may be amenable to manipulation.
Citation: Flores R, Shi J, Gail MH, Gajer P, Ravel J, Goedert JJ (2012) Association of Fecal Microbial Diversity and Taxonomy with Selected Enzymatic Functions. PLoS ONE 7(6): e39745. https://doi.org/10.1371/journal.pone.0039745
Editor: Sarah K. Highlander, Baylor College of Medicine, United States of America
Received: March 16, 2012; Accepted: May 25, 2012; Published: June 28, 2012
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This project (Z01-CP010214) was funded by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
The human intestinal microbial population is comprised of at least a trillion bacterial cells per gram of feces.  Most of these bacteria can be classified into 400–800 individual species, the majority of which are only known by sequence analysis. ,  This gut microbial reactor is in close balance with the human host as it protects against pathogens, detoxifies potential poisons, produces energy and nutrients by digestion of food and de novo synthesis, conditions and maintains mucosal and systemic immunity, and facilitates homeostasis. , .
How the microbiota exerts these effects is starting to be understood using modern sequencing approaches, with which the genetic potential of a microbial community can be discerned. By using these culture-independent methods, researchers have started to obtain insight with respect to broad functional activities of the intestinal microbiota. – Yet, the interrelationships of genomic sequence analysis with specific bacterial functions and their role in host homeostasis is still poorly defined, in part because metagenomics only interrogates functional potential of a gene, not gene expression. Global assessment of microbial functions is not yet possible. However, advances can be made by studies of selected microbial enzymatic activities that are highly relevant to survival of the organism, as well as to disease in the human host.
Recent analysis of the gut microbiota using a deep sequencing approach has identified β-glucuronidase as a conserved function among bacteria colonizing the human gastrointestinal tract.  β-glucuronidases are believed to be an important and critical component in the cleavage of xenobiotic compounds and conjugated hormones that, once free, can re-enter the human body via enterohepatic circulation. The clinical relevance is that sustained systemic hormone levels via β-glucuronidase activity could contribute to hormone-sensitive pathologies such as the increased risk of breast cancer in postmenopausal women who have high endogenous estrogen levels.  On the other hand, recent studies suggest a hormone-related protection of colorectal cancer via enzymatic activation of phytoestrogens and other compounds found in fish oil, cruciferous vegetables, and estrogens.  β-glucosidases on the other hand, seem to have a more general role in the bioavailability of plant polyphenols and the extraction of energy from insoluble fibers and other indigestible carbohydrates.  Characterization of β-glucuronidases and β-glucosidases have shown that these important functions are selectively expressed by members of the gut microbiota and that diet composition partially explains the induction of genes expressing these enzymes. ,  This suggests that the gut microbiota is a robust system that interconnects and is controlled by multiple factors and at multiple levels. A better understanding of the role of these enzymes in health and disease and their relationship with microbial diversity is needed.
In this study of healthy volunteers, we correlate functional activities of β-glucuronidase and β-glucosidase of the human gut microbiota with measures of microbial diversity and taxonomy. The goal is to identify microbial parameters that can provide insight on human-microbe homeostasis and that might serve as surrogates of bacterial functions.
In specimens provided by 51 volunteers (26 female, mean age 39, range 17–65 years), fecal β-glucuronidase and β-glucosidase activity levels were significantly correlated (R = 0.60, P = 0.0001). The enzyme activity levels had few significant associations with corresponding demographic or questionnaire parameters (Table 1). β-glucuronidase was 2.3-fold (e0.85) higher among participants who reported having lost at least 5 lb body weight in the previous year (P = 0.03). Weight loss was not related to β-glucosidase level, and neither enzyme was related to body mass index (BMI) overall. The four vegetarians had 0.57-fold (e−0.56) lower β-glucosidase levels (P = 0.06). Although antibiotics and other prescription medications used within the previous six months were strongly associated with fecal microbiome alpha diversity,  they were not associated with enzyme activities (Table 1).
In contrast to the questionnaire data, both enzymes were directly and significantly correlated with four different measures of microbial richness and alpha diversity, indicating higher enzyme activity with higher microbial diversity (Table 2). Although all were statistically significant, the enzyme activities were less strongly associated with the alpha diversity measures that standardize for multiple copies of the same OTU (i.e., Chao1 and Shannon) and more strongly with counts of observed species (P = 0.01 for β-glucuronidase, P = 0.007 for β-glucosidase) and with phylogenetic distance (PD) whole tree (P = 0.002 for β-glucuronidase, P = 0.001 for β-glucosidase).
Principal component (PC) analysis on the sample similarity matrix was used to derive 10 PC vectors as measurements of beta diversity. These PCs explained very little of the variance. Nonetheless, the first PC (7% of variance) and especially the second PC (6% of variance), but none of the other PCs, were significantly associated with reduced levels of both enzymes (Table 2). The Shannon index was significantly reduced with the second PC (R = −0.71) but not with the first PC (R = −0.08); correlations with the other measures of alpha diversity were very similar (Results not presented).
Turning to taxonomy, we examined 61 taxa with a mean relative abundance ≥0.1%, including bacteria in 5 defined phyla, 55 genera, and an unclassified group. The activities of one or both enzymes were associated with the relative abundance of eight genera, but they were not associated with the two major or three minor phyla (Table 2). Inverse associations, especially for β-glucosidase, were found with the abundance of two Firmicutes, Streptococcus and Roseburia. Activities of both enzymes were directly associated with the abundance of Alistipes in the phylum Bacteroidetes and also with the abundance of five Clostridia genera, especially Ruminococcaceae, Subdoligranulum and non-Clostridiales (Table 2). The taxa associated with high enzyme activities appeared to be under-represented in the second PC (R = −0.45 to −0.73).
We examined how the activities of two fecal microbial enzymes related to demographics of study participants, simple dietary factors, antibiotics and other medications, and especially to diversity and taxonomy of the distal human gut microbiome. Our major finding was that the activities of both enzymes were directly correlated with increased alpha diversity and especially with increased richness of the fecal microbiome. This complements our finding that the enzyme activities were associated with the abundance of a few relatively rare bacterial taxa, but not with the abundance of the major bacterial phyla. Likewise, in our beta diversity analysis, enzyme activities were significantly reduced in two distinct microbial communities, one of which (PC2) was sparsely populated with the high-enzyme activity taxa. Not withstanding evidence of in vitro β-glucosidase activity of several cultured strains of Firmicutes and Bifidobacteria in the phylum Actinobacteria,  our findings suggest that β-glucuronidase and β-glucosidase enzymatic functions in our participants were mostly performed by particular genera rather than by the microbial community at large.
Activities of both enzymes were directly associated with higher abundance of five Clostridia genera in the phylum Firmicutes, especially with Ruminococcaceae, Subdoligranulum and non-Clostridiales, largely complementing and corroborating in vitro results, such as the previously noted high prevalence of the classical gus gene and β-glucuronidase activity among Ruminococcaceae isolates. , , ,  Comparison of our results to the in vitro studies is difficult, but some differences should be noted. ,  We found that activity levels of both enzymes had significant inverse associations with the relative abundance of Roseburia, whereas Dabek and colleagues noted that all eight Roseburia strains examined produced β-glucosidase and six of these also produced β-glucuronidase.  Moreover, Gloux et al found one Roseburia strain that harbored a newly discovered class of genes with β-glucuronidase (BG) activity.  Perhaps of interest, this class of BG genes also was found in strains of Ruminococcaceae Subdoligranulum,  a genus for which relative abundance was directly correlated with the activity levels of both enzymes in our study. Enzyme activities in our study also were directly associated with the abundance of Alistipes in the phylum Bacteroidetes, which did not harbor the newly discovered BG genes, but which also has not been evaluated for in vitro production of β-glucuronidase or β-glucosidase. ,  GenBank notes that the complete genome of Alistipes shahii WAL 8301 (Accession number FP929032), a gut isolate, contains seven copies of a BG gene. Further annotation, functional and metatranscriptomic approaches are clearly needed to discern whether the enzymatic levels detected in vivo correspond to a few highly active and readily inducible genes, or to more modest expression by multiple glycosidase genes acting in concert.
β-glucuronidase and other glycosidases are known to be expressed in a variety of microorganisms. In cultured specimens, Mroczynska and Libudzisz found that β-glucuronidase and β-glucosidase were produced at higher levels by Lactobacillus than by Enterococcus in fecal isolates that were obtained from people ages 1 to 80.  In environmental water specimens, β-glucuronidase was produced by several unidentified isolated gram-negative bacteria, by unidentified Bacillus species in the phylum Firmicutes, and by Escherichia coli (E. coli).  Several other Proteobacteria Enterobacteriaceae species, in addition to E. coli, can produce β-glucuronidase.  In our study, enzyme activities were not associated with E. coli, but this organism had a mean relative abundance of only 0.001%. At the phylum level, neither Proteobacteria nor Firmicutes correlated with the activities of β-glucuronidase or β-glucosidase.
Only two associations with our demographic and questionnaire data were noteworthy, perhaps suggesting that all human gut microbiota require these enzymatic functions. Our four vegetarians had lower β-glucosidase levels, resembling the observation of Ling and Hänninen, who reported that activities of both β-glucosidase and β-glucuronidase decreased within one week of changing from an omnivorous to an uncooked vegan diet.  Conversely, we noted significantly higher β-glucuronidase activity in participants who had lost weight. This observation is in agreement with a recent study reporting increase in β-glucuronidase activity in obese volunteers following a weight-loss diet.  Koning and colleagues saw an immediate decline in fecal β-glucuronidase activity during one week on amoxicillin, but this activity normalized within two months.  Thus, our null associations with antibiotic use within the previous six months are not surprising.
The primary limitations of our study are its small size, cross-sectional design, and lack of expression data or in vitro systems to explore the regulation and determinants of microbial enzymatic and other functions. It also was limited by the possibility that relatively rare taxa were misclassified with the Ribosomal Database Project due to sequencing errors, which precluded taxonomic comparisons below the genus level. Nonetheless, given the paucity of understanding, our study makes a useful contribution by demonstrating that β-glucuronidase and β-glucosidase activities are directly correlated with microbiome diversity and with particular genera. These findings suggest that these important functions are primarily accomplished by specialist organisms rather than by the community as a whole. If replicated and characterized in greater depth, perhaps the number of observed species could serve as a biomarker for these enzymatic functions, and ultimately particular strains or pathways might be exploited to improve health and reduce the risk of disease.
Participants and Ethics
We studied 51 employees of the Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI) who were recruited following approval by the NCI Special Studies Institutional Review Board and with signed informed consent. There were no exclusion criteria. In addition to collected specimens, a brief questionnaire was administered to all participants to gather general information on demographics, health, medication use and disease conditions that may affect the gut microbiota.
Specimen collection and assay methods are reported elsewhere. ,  Briefly, from four fecal aliquots self-collected in RNAlater using two devices [Polymedco OC-auto collection device and Sarstedt fecal collection tube (Nümbrecht, Germany)], DNA was extracted and amplified by PCR targeting the V1–V2 region of the 16S rRNA gene. Pyrosequencing of the barcoded amplicons yielded 1,270,073 raw reads that were edited, de-noised, and assigned at 97% or greater similarity to a mean of 431 operational taxonomic units (OTUs) per participant.  OTUs from the four aliquots were averaged for the current analysis.
To assess an important function of the microbiota, deconjugation of glycosylated metabolites, β-glucuronidase and β-glucosidase activities were determined in triplicate by colorimetric enzyme kinetic assays in four replicates from the same stool that were independently collected by each participant in phosphate buffered saline.  These methods yielded highly reproducible estimates of alpha diversity, beta diversity, classification into the most abundant bacterial phyla, and functional activities of the two microbial enzymes. ,  Because reproducibility of β-glucosidase activity with the Polymedco device was significantly lower than with the Sarstedt device,  the current analysis was restricted to the activities with the two Sarstedt devices, each run in triplicate, which were then averaged.
Alpha diversity measurements of the OTUs were generated with the QIIME pipeline (http://qiime.sourceforge.net). The sample similarity matrix was produced using unweighted UniFrac analysis in the QIIME pipeline. We then performed principal component (PC) analysis on the sample similarity matrix and derived 10 PC vectors as measurements of beta diversity. The sequences were assigned to taxa with the Ribosomal Database Project (RDP) naïve Bayesian classifier  and the Visualization and Analysis of Microbial Population Structures (VAMPS, Marine Biology Laboratories, Woods Hole, MA) pipeline.
Pearson’s correlation was used to assess the relationship between the activities of the two enzymes. The relationship between the two enzymatic activity levels and parameters of alpha diversity, beta diversity, and the questionnaire data [age, sex, body mass index (BMI), weight loss or gain, certain dietary characteristics, and use of antibiotics or other prescription medications] was estimated with Pearson’s correlation. Linear regression was used to test the association of enzymatic activity levels (average across triplicates with the paired Sarstedt devices, natural log-transformed) with multiple measures of alpha diversity and with relative abundance of 61 taxa, including phyla and selected genera [restricted to relative abundance ≥0.1% and ordered as zero, low (below median detected) and high (above median)]. Significance was based on trend tests or two-sided categorical tests with α = 0.05. Taxonomic associations with either enzyme that had nominal P≤0.05 are presented. Bonferroni was used to correct for 61 multiple comparisons.
Conceived and designed the experiments: RF JJG. Performed the experiments: RF JR. Analyzed the data: JS MHG PG. Contributed reagents/materials/analysis tools: JR. Wrote the paper: RF JJG.
- 1. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312: 1355–1359. doi 10.1126/science.1124234.
- 2. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59–65. doi 10.1038/nature08821.
- 3. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI (2011) Human nutrition, the gut microbiome and the immune system. Nature 474: 327–336. doi 10.1038/nature10213.
- 4. Relman DA (2011) Microbial genomics and infectious diseases. N Engl J Med 365: 347–357. doi 10.1056/NEJMra1003071.
- 5. Zhu B, Wang X, Li L (2010) Human gut microbiome: the second genome of human body. Protein Cell 1: 718–725. doi. pp. 10.1007/s13238–010-0093-z.
- 6. Turnbaugh PJ, Henrissat B, Gordon JI (2010) Viewing the human microbiome through three-dimensional glasses: integrating structural and functional studies to better define the properties of myriad carbohydrate-active enzymes. Acta Crystallogr Sect F Struct Biol Cryst Commun 66: 1261–1264. doi 10.1107/S1744309110029088.
- 7. Gloux K, Berteau O, El OH, Beguet F, Leclerc M, et al. (2011) A metagenomic beta-glucuronidase uncovers a core adaptive function of the human intestinal microbiome. Proc Natl Acad Sci U S A 108 Suppl 1: 4539–4546. doi 10.1073/pnas.1000066107.
- 8. Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, et al. (2011) Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 105: 709–722. doi 10.1038/bjc.2011.254.
- 9. Barone M, Lofano K, De TN, Licino R, Albano F, et al. (2012) Dietary, endocrine, and metabolic factors in the development of colorectal cancer. J Gastrointest Cancer 43: 13–19. doi. pp. 10.1007/s12029–011-9332-7.
- 10. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79: 727–747.
- 11. Dabek M, McCrae SI, Stevens VJ, Duncan SH, Louis P (2008) Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria. FEMS Microbiol Ecol 66: 487–495. doi 10(1111/j.1574-6941.2008.00520): x.
- 12. McIntosh FM, Maison N, Holtrop G, Young P, Stevens VJ, et al. (2012) Phylogenetic distribution of genes encoding beta-glucuronidase activity in human colonic bacteria and the impact of diet on faecal glycosidase activities. Environ Microbiol. doi 10(1111/j.1462-2920.2012.02711): x.
- 13. Flores R, Shi J, Gail MH, Gajer P, Ravel J, et al. (2012) Assessment of the human faecal microbiota: II. Reproducibility and associations of 16S rRNA pyrosequences. Eur J Clin Invest. doi 10(1111/j.1365-2362.2012.02659): x.
- 14. Cole CB, Fuller R, Mallet AK, Rowland IR (1985) The influence of the host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds. J Appl Bacteriol 59: 549–553.
- 15. Nakamura J, Kubota Y, Miyaoka M, Saitoh T, Mizuno F, et al. (2002) Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces. Microbiol Immunol 46: 487–490.
- 16. Mroczynska M, Libudzisz Z (2010) Beta-glucuronidase and beta-glucosidase activity of Lactobacillus and Enterococcus isolated from human feces. Pol J Microbiol 59: 265–269.
- 17. Tryland I, Fiksdal L (1998) Enzyme characteristics of beta-D-galactosidase- and beta-D-glucuronidase-positive bacteria and their interference in rapid methods for detection of waterborne coliforms and Escherichia coli. Appl Environ Microbiol 64: 1018–1023.
- 18. Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, et al. (2008) Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. Cancer Biol Ther 7: 1919–1925.
- 19. Ling WH, Hanninen O (1992) Shifting from a conventional diet to an uncooked vegan diet reversibly alters fecal hydrolytic activities in humans. J Nutr 122: 924–930.
- 20. Koning CJ, Jonkers DM, Stobberingh EE, Mulder L, Rombouts FM, et al. (2008) The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol 103: 178–189. doi 10(1111/j.1572-0241.2007.01547): x.
- 21. Flores R, Shi J, Gail MH, Ravel J, Goedert JJ (2012) Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities. Eur J Clin Invest.x.
- 22. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, et al. (2009) The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37: D141–D145. doi 10.1093/nar/gkn879.